1 / 6

Vaccine Market Expected to Reach $54.17 Billion by 2027

The growth of the global vaccine market is attributed to increase in incidence of infectious diseases and promising vaccines in late stage of pipeline majorly drives the market growth. Furthermore, surge in investments by government on immunization programs and rise in awareness for immunization in developing countries further contribute toward the growth of the market.

Millerpeet
Download Presentation

Vaccine Market Expected to Reach $54.17 Billion by 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vaccine Market Expected to Reach $54.17 Billion by 2027 www.alliedmarketresearch.com

  2.  The growth of the global vaccine market is attributed to increase in incidence of infectious diseases and promising vaccines in late stage of pipeline majorly drives the market growth. Furthermore, surge in investments by government on immunization programs and rise in awareness for immunization in developing countries further contribute toward the growth of the market.  The global vaccine market size accounted for $32,462 million in 2019, and is expected to reach $54,150 million by 2027, registering a CAGR of 6.6% from 2020 to 2027. Request Sample Report at:https://www.alliedmarketresearch.com/request-sample/258 www.alliedmarketresearch.com

  3. High prevalence of diseases worldwide, surge in government focus towards immunization programs, and the emergence of technologically advanced vaccines drive the growth of the global vaccines market. Additionally, the prospect of high growth in emerging economies provides lucrative opportunities for emerging market players. However, high duration for vaccine production and high cost associated with it impede market growth. www.alliedmarketresearch.com

  4. Asia-Pacific has witnessed highest growth rate for vaccines, and is expected to continue this trend. This is attributed to increase in sizeable population, rise in incidence of HIV & cancer cases, healthcare infrastructural development, and huge market potential, owing to the new arrival of preventive, therapeutic, and adult vaccines by key players focusing on the emerging markets. For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/258 www.alliedmarketresearch.com

  5. Leading players • AstellasPharmaInc. • AstraZeneca Plc. (Medimmune, LLC.) • CSL Limited • Emergent Biosolutions, Inc. • GlaxoSmithKline Plc. • johnson& Johnson • Merck & Co., Inc. • Pfizer Inc. • Sanofi Pasteur • Serum Institute of India Pvt. Ltd.  www.alliedmarketresearch.com

  6. ContactUs: David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesUSA/Canada (Toll Free):+1-800-792-5285, +1-503-894-6022, +1-503-446-1141UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060help@alliedmarketresearch.com www.alliedmarketresearch.com

More Related